Blocking Sugar Degradation Prevents HIV Brain Aging and Memory Loss
Scientists find that preserving glycans on cell surfaces blocks HIV-driven inflammaging and cognitive decline — a potential new treatment target.
Summary
Researchers discovered that HIV accelerates cognitive decline partly by degrading glycans — sugar molecules coating cell surfaces — specifically by stripping away sialic acid and galactose. These glycomic changes, markers of premature aging, were more pronounced in HIV-positive individuals with cognitive impairment, especially women. Using two complementary mouse models, the team showed that pharmacologically inhibiting sialidase enzymes — which drive glycan degradation — prevented viral inflammation, immune activation, accelerated aging hallmarks, and memory deficits. The findings suggest that protecting the glycan layer on cells may be a novel strategy to combat inflammaging and neurological deterioration associated with chronic viral infections like HIV.
Detailed Summary
Chronic viral infections like HIV are associated with accelerated biological aging and cognitive decline, yet the mechanisms linking viral persistence to brain deterioration have remained elusive. This study proposes a compelling new contributor: pro-inflammatory glycan degradation, the stripping of sialic acid and galactose from cell-surface sugar molecules, both recognized hallmarks of premature aging.
The research team analyzed two human cohorts of people living with HIV, comparing those with and without HIV-associated cognitive impairment (HIV-CI). They found that degradative glycomic changes were significantly enriched in individuals with cognitive impairment, with female participants showing a particularly pronounced pattern. These glycan alterations correlated directly with worse cognitive performance scores.
To establish causality, the investigators turned to two complementary mouse models: a humanized mouse model of HIV infection and an EcoHIV model that permits direct cognitive behavioral testing. In both systems, pharmacological inhibition of sialidase enzymes — the enzymes responsible for cleaving sialic acid — successfully prevented virally induced systemic inflammation, immune activation, accelerated aging markers, and measurable memory deficits.
The implications are significant for the roughly 39 million people living with HIV globally, many of whom now survive into older age on antiretroviral therapy but face disproportionate rates of neurocognitive disorders. Glycan preservation via sialidase inhibitors represents a potentially repurposable pharmacological strategy, as sialidase inhibitors already exist in clinical medicine (e.g., neuraminidase inhibitors used for influenza).
Key caveats include reliance on an abstract-only summary, meaning full statistical details and effect sizes are unavailable. The human data are observational and correlational, while causal evidence comes from mouse models, which may not fully recapitulate human HIV-CI. Sex-specific findings in females warrant dedicated follow-up studies.
Key Findings
- Loss of sialic acid and galactose glycans correlates with cognitive impairment in people living with HIV.
- Glycan degradation changes were most pronounced in HIV-positive females with cognitive decline.
- Sialidase inhibitors prevented viral inflammation, immune activation, and memory deficits in two mouse models.
- Glycan degradation is identified as a driver of HIV-associated inflammaging and premature aging hallmarks.
- Glycan preservation is proposed as a novel therapeutic strategy for viral-infection-related cognitive decline.
Methodology
The study combined analysis of two human HIV cohort datasets stratified by cognitive status with interventional experiments in two mouse models: a humanized HIV mouse model and an EcoHIV model enabling direct cognitive behavioral testing. Pharmacological sialidase inhibitors were used to test causal roles of glycan degradation in vivo.
Study Limitations
Causal evidence is currently limited to mouse models, which may not fully reproduce human HIV-associated cognitive impairment pathophysiology. Human cohort data are observational and cannot establish causality on their own. Full methodology and statistical details are unavailable as only the abstract was accessible for this summary.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: